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Three decades after the unobtrusive debut of the peroxi- 
some as a distinct subcellular organelle, biologists are 
paying attention to the special bag of tricks eukaryotic 
cells use to entice peroxisomal proteins from their site of 
synthesis in the cytosol to the peroxisome. In this minire- 
view, we highlight some of the recent findings that have 
emerged, emphasize their significance, and contrast them 
with aspects of protein import into other subcellular desti- 
nations. 
Peroxisomal Targeting Signals - The Beginning, 
the Middle, and the End 
Genetic and biochemical evidence has underscored the 
conservation of peroxisomal targeting signals (PTSs) from 
yeast to humans and led to the elucidation of at least two 
pathways for the transport of proteins to the peroxisome 
matrix (lumen). Each of these pathways is dependent on 
the molecular recognition of a specific PTS by its cognate 
receptor, which then hands off the protein to a putative 
translocation machinery housed in the peroxisome mem- 
brane. PTSl is a conserved C-terminal tripeptide (SKL or 
a variant) that constitutes the major targeting signal for 
proteins destined for the peroxisome matrix. In contrast, 
PTS2 is a conserved N-terminal nonapeptide (R/K)(L/V/I) 
(X)5(H/Q)(L/A) used by a smaller subset of peroxisomal 
matrix proteins. Other internally located PTSs have been 
described but remain poorly characterized (Purdue and 
Lazarow, 1994). 
Peroxisomal membrane proteins do not possess either 
PTSl or PTS2 sequences but are endowed instead with 
PTSs that have been defined only as fairly large internal 
segments of peroxisomal membrane proteins (Purdue and 
Lazarow, 1994). 
Despite the fact that all these PTSs are known to be 
necessary and sufficient for targeting to peroxisomes, a 
novel twist (addressed later) is the recent discovery that 
polypeptide chains devoid of a PTS can hitch a ride into 
peroxisomes by association with subunits that contain a 
PTS (Glover et al., 1994; McNew and Goodman, 1994). 
Omnipresent PTS Receptors 
Yeast and human cells selectively deficient in the PTS1 
or PTS2 import pathway (or both) have been instrumental 
in the identification of PTS receptors. The earliest mutant 
discovered to be selectively compromised in the PTSl 
pathway alone was the pas8 mutant of Pichia pastoris. 
The protein, Pas8p, is tightly associated with the cytosolic 
face of the peroxisome membrane and is the PTSl recep- 
tor (PTSl R) (Terlecky et al., 1995; Figure 1). 
Minireview 
Surprisingly, homologs of Pas8p that complement mu- 
tants with pasb-like phenotypes in other yeasts exhibit dif- 
ferent subcellular locations ranging from cytosolic (e.g., 
PaslOp of Saccharomyces cerevisiae [van der Leij et al., 
19931; Per3p of Hansenula polymorpha [van der Klei et al., 
19953) to intraperoxisomal (Pay32p of Yarrowia lipolytica 
[Szilard et al., 1995)). Likewise, the human PTSlR has 
been reported by some groups to be primarily cytosolic 
and partly peroxisomal (Dodt et al., 1995; Wiemer et al., 
1995) and by others to be exclusively peroxisomal (Fransen 
et al., 1995). 
Equally puzzling results have emerged from studies 
with the PTSP receptor (PTS2R). Complementation of the 
S. cerevisiae pas7 mutant, deficient only in the PTS2 im- 
port pathway, led to the isolation of thePAS7gene, thought 
to encode PTS2R. Marzioch et al. (1994), who reported 
Pas7p to be primarily cytosolic and only partially associ- 
ated with peroxisomes, proposed a model in which PTS2R 
shuttles between the cytosol and the peroxisome mem- 
brane. In contrast, Zhang and Lazarow (1995) reported 
Pas7p to be intraperoxisomal and suggested instead that 
it might actasachaperone,andnotasareceptor, in pulling 
PTSBcontaining proteins into the peroxisome. While the 
resolution of this discrepancy may stem eventually from 
the details of the different epitope-tagged molecules local- 
ized or, alternatively, from the levels of expression used, 
one is hard pressed to reconcile how the same protein 
could be in such different locations unless these locations 
are linked to the biological functions of the protein. 
Shuttling Receptors or Experimental Illusions? 
If the multiple subcellular locations of PTSl R and PTS2R 
are real and, perhaps, dependent on the physiological sta- 
tus of a cell, several critical issues must be addressed. 
Do all subcellular forms of the receptors bind PTSs? How 
are the receptors distributed quantitatively in each loca- 
tion, and which of these pools is physiologically related 
to protein import? Do the receptors shuttle between the 
cytosol and the peroxisome membrane, as shown in Fig- 
ure 2, and are there any circumstances under which the 
failure to release the receptors from the peroxisome mem- 
brane results in transport of the receptor to the matrix in 
association with their PT.5containing ligands, as alluded 
to earlier (see box in Figure 2)? Alternatively, is there a 
specific signal that targets the receptors to the matrix? 
Are the receptors that are found in the matrix actively en- 
gaged in protein import, or are they deadend molecules? 
Can receptors shuttle back out of the peroxisome to facili- 
tate multiple rounds of import? If any of these unorthodox 
mechanisms is correct, peroxisomal protein import would 
be very different from protein import across the endoplas- 
mic reticulum, mitochondrial membranes, or chloroplast 
membranes. 
PTS Receptors and Human Disease 
The remarkable conservation of PTSs and PTSl R homo- 
logs in different yeasts, as well as the similar phenotypes 
of the yeast mutants defective in the PTSl pathway alone, 
suggested that a protein homologous to P. pastoris Pas8p 
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Figure 1. Model Showing the Involvement of 
PTSlR and PTSZR in Peroxisomal Protein 
Import 
Folded PTSI-containing proteins bind to either 
the peroxisome-associated PTSl R (e.g., P. 
pastoris Pas6p) or the cytosolic PTSl R (e.g., 
human PTSI R). The TPR motifs of Pas8p are 
known to be required for binding to the PTSl 
peptide. Folded PTS2-containing proteins bind 
to the cytosolic PTS2R, which may correspond 
either to S. cerevisiae Pas7p or to an as yet 
unidentified protein. PTS2R is shown binding 
the PTS2 motif; however, it is unclear whether 
this binding is direct or indirect. Cytosolic 
PTSl R and PTSZR bound to their appropriate 
ligands then associate with peroxisomal inte- 
gral membrane proteins (hatched), which form 
part of the translocation complex or which de- 
liver the ligands to a translocation complex lo- 
cated elsewhere in the peroxisome membrane. 
The two receptors are shown as either inter- 
acting with distinct PTSI-specific and PTS2- 
specific translocation complexes (left and right, 
respectively) or with common translocation 
complexes (center). Protein multimers com- 
posed of subunits with and without PTSl or PTS2 motifs can be imported into peroxisomes (see dimers and trimers) via the same PTSI and PTSP 
pathways shown for the import of monomers. Protein unfolding is not required for peroxisomal protein import. Following translocation into the 
matrix, PTS2-containing proteins are shown to be proteolytically processed so that the N-terminal leader sequence is cleaved (as in thiolase). The 
hypothetical “interaction” (see text) between the ligand-bound PTSIR and PTSPR in human cells is also depicted. 
might be conserved in humans. An important impetus to 
the search for a human homolog was the clinical documen- 
tation over the last 30 years of a series of extremely debili- 
tating (and invariably fatal) human peroxisomal disorders. 
These disorders fall into three groups: A, 6, and C. In 
group C, the enzymatic activity or the subcellular localiza- 
tion of asingle peroxisomal protein is compromised. Disor- 
ders of groups A and B are more interesting because, 
although a single gene is affected in each patient, multiple 
peroxisomal proteins are often mislocalized to the cytosol. 
Cells from these patients have peroxisome “ghosts” miss- 
ing a few, or many, of the contents of the peroxisome 
matrix. That these diseases exhibit deficiencies in the 
PTSl or PTS2 import pathways is well documented (Mot- 
ley et al., 1994). 
The group A disorders (Zellweger syndrome, neonatal 
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Figure 2. Model for the Dynamics of PTS Re- 
ceptors 
The cytosolic localization and peroxisome 
membrane association of PTSl R and PTSZR 
could be explained by shuttling of the receptors 
between the cytosol and the peroxisome mem- 
brane during rounds of transport of PTS- 
containing proteins from the cytosol to the per- 
oxisome-associated translocation machinery. 
In this model, hypothetical proteins (hatched) 
function either as “gatekeepers” to obstruct the 
entry of PTS receptors into the matrix in associ- 
ation with their PTS-containing ligands or as 
“recyclers” to facilitate the return of the recep- 
tors to the cytosol. Under certain physiological 
or artificially created conditions, the absence 
of such proteins might result in the entry of 
the receptors into the matrix (see stippled box), 
explaining their matrix localization. In such a 
hypothetical model, a key question is whether 
mechanisms exist for the export of the recep- 
tors from the matrix back to the cytosol. An 
alternative explanation for the presence of 
PTS-binding proteins inside peroxisomes is 
that they receive PTS-containing proteins 
translocated across the peroxisome mem- 
brane from other receptors located on the cyto- 
solic face of peroxisomes. 
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adrenoleukodystrophy, infantile Refsum disease, and hy- 
perpipecolic acidemia) fall into at least ten complementa- 
tion groups. Cells from all complementation groups are 
deficient in the PTSl and PTS2 import pathways, but cells 
from one patient in complementation group 2 are selec- 
tively deficient (like the P. pastoris pas8 mutant) in only 
the PTSl pathway (Motley et al., 1994). 
A cDNA encoding the human PTSl R has been isolated 
both by recent screens of human cDNA libraries with ex- 
pressed cDNA sequence tags homologous to the PAS8 
sequence (Dodt et al., 1995; Wiemer et al., 1995) and by 
a search for proteins interacting with the PTSl topogenic 
signal as bait in a yeast two-hybrid system (Fransen et 
al., 1995). Cells from patients in complementation group 
2 with Zellweger syndrome or neonatal adrenoleukodys- 
trophy have mutations in their PTSlR gene (Dodt et al., 
1995). Furthermore, the human PTSlR can complement 
the protein import defect in these cells (Dodt et al., 1995; 
Wiemer et al., 1995). Collectively, these studies provide 
an understanding of the molecular basis of the protein 
import deficiencies in a subset of generalized peroxisomal 
disorders. 
A hallmark of cells from group 6 patients with the dis- 
ease rhizomelic chondrodysplasia punctata (RCDP) is that 
they are deficient only in the PTSP import pathway (like 
the S. cerevisiae pas7 mutant; Marzioch et al., 1994; Zhang 
and Lazarow, 1995). The human homolog of the PAS7 
gene would therefore constitute an excellent candidate 
for the gene mutated in RCDP patients, although other 
possibilities cannot be excluded. 
Links between PTSl and PTSP Pathways? 
The yeast and human PTSl Rs belong to the tetratricopep- 
tide (TPR) family of proteins, which share a loosely con- 
served 34 amino acid repeat. These repeats bind the PTSl 
sequences (Terlecky et al., 1995). Based on genetic inter- 
actions between other TPR proteins and polypeptides con- 
taining a WD40 repeat motif, is there such a WD40 repeat 
partner for PTSl R? 
Intriguingly, the S. cerevisiae PTSPR, Pas7p, is itself a 
WD40 repeat protein (Marzioch et al., 1994; Zhang and 
Lazarow, 1995). One line of evidence pointing tantalizingly 
to a possible interaction between PTSlR and PTS2R is 
the observation that a Zellweger syndrome patient whose 
cells fail to synthesize PTSlR is also impaired in PTS2 
import. Both import pathways are restored upon comple- 
mentation with the human PTSlR cDNA (Wiemer et al., 
1995). However, rigorous biochemical evidence for such 
interactions between the two receptors and the physiologi- 
cal significance of such an association are lacking. 
Ticketless Hitchhikers 
In contrast to mitochondria and chloroplasts, peroxisomes 
can translocate oligomeric proteins across their mem- 
branes. Working with S. cerevisiae peroxisomal thiolase, a 
homodimer, Glover et al. (1994) showed that a population, 
consisting of equal proportions of full-length thiolase mono- 
mers (with a PTS2 peptide) and monomers lacking their 
PTS2 motifs, assembles randomly into dimers in the cyto- 
sol, and only dimers containing at least one PTS2 can then 
be translocated into the peroxisome. A thiolase monomer 
lacking its PTS2 could dimerize with a full-length thiolase 
monomer containing a PTS2 and effectively translocate 
in a “piggyback” fashion on the full-length subunit into the 
peroxisome matrix. Glover et al. (1994) could also show 
that there was no mixing of thiolase subunits at any time 
during or subsequent to the translocation event, and there- 
fore thiolase was translocated across the peroxisome 
membrane as a dimer and remained as a dimer composed 
of subunits that were originally translocated together (Fig- 
ure 1). 
The ability to translocate oligomeric forms of proteins 
is not reserved solely for the PTS2 pathway. McNew and 
Goodman (1994) showed that the bacterial enzyme chlor- 
amphenicol acetyl transferase [CAT) containing SKL or 
AKL PTSl motifsassembled into the mature homotrimeric 
form of CAT in S. cerevisiae and was imported into peroxi- 
somes as a trimer. Like thiolase, a CAT subunit devoid of 
a PTSl sequence could assemble with subunits con- 
taining the motif and be transported as a subunit of a tri- 
merit molecule into the peroxisome of both yeast and 
mammalian cells (Figure 1; McNew and Goodman, 1994). 
Delivering Gold to Peroxisomes 
Whether thiolase dimers or CAT trimers are translocated 
across the peroxisome membrane in an extended or com- 
pact conformation is unknown. However, work by Walton 
et al. (1995) demonstrates that prefolded proteins stabi- 
lized with disulfide bonds and chemical crosslinkers are 
substrates for peroxisomal import, as are mature folded 
and disulfide-bonded immunoglobulin G molecules con- 
taining the PTSl motif. Indeed, even 9 nm gold particles 
decorated with the PTSl motif could be imported into per- 
oxisomes. So far, no upper limit has been determined for 
the size of a molecule or particle that can be imported 
specifically into peroxisomes. 
The ability to translocate protein oligomers and large, 
stable particles across a membrane leads to interesting 
models for peroxisomal protein import. The results sug- 
gest the existence of pores in the peroxisome membrane 
capable of translocating very large protein structures; 
however, there is no direct evidence for such pores. Alter- 
natively, some form of pinocytosis or endocytosis at the 
level of the peroxisome membrane could be invoked for 
the translocation of protein oligomers (McNew and Good- 
man, 1994). Again, no such vesicles have been observed 
inside peroxisomes in normal or mutant cells. Such a sys- 
tem would also raise puzzling questions regarding the fate 
of the invaginated membranes and the mechanism of the 
intraperoxisomal release of the vesicular contents. 
The transport of folded or oligomerized proteins across 
the peroxisome membrane does not preclude the possibil- 
ity that certain proteins might indeed be unfolded or main- 
tained as monomers during the import process. The dy 
namics of assembly of certain multimeric proteins with 
associated cofactors is likely to be more complex and may 
in fact require chaperones in the cytosol or inside the per- 
oxisome matrix to facilitate orderly protein assembly and 
to prevent nonspecific aggregation. 
Entry by Association 
Since subunits lacking a PTS can associate with subunits 
containing a PTS to be translocated together across the 
peroxisome membrane, there is the possibility of cytosolic 
Cell 
528 
polypepticles oligomerizing with peroxisomal matrix poly- 
peptides to gain access to the peroxisome. This form of 
targeting in tram remains hypothetical and is different 
from what one has come to expect from studies of other 
organelles. Furthermore, it raises a caveat for future tar- 
geting studies. Domains required for multimerization with 
proteins containing PTS motifs could readily be confused 
with the PTSs themselves. The identification of receptor 
molecules that recognize and bind true PTSs should lead 
to discrimination between these two alternatives. 
A picture of how proteins are imported into peroxisomes 
is starting to emerge. What is readily apparent is that cells 
have developed unique solutions to the problem of moving 
proteins from their initial site of synthesis on cytoplasmic 
polysomes to their final destination inside the peroxisome. 
These solutions will undoubtedly lead to a better under- 
standing of the evolution of this organelle. 
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